Mezotelióma: vizsgálatok itt: Kína
15 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.
- 1/2. fázisTaking peopleRinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
- Where
- Beijing, Changchun, Changsha, Chengdu, Chongqing, Fujian, Guangdong, Hangzhou, Henan, Hubei, Nanchang, Shanghai, Shanxi, Shengyang, Tianjin
- Életkor
- 18 év and over
- People
- 952 worldwide
- Run by
- Genmab
See details and how to joinNCT05579366 - 1/2. fázisTaking peopleEfficacy and Safety of Ivonescimab Plus Pemetrexed and Platinum-Based Chemotherapy in Advanced Malignant Pleural Mesothelioma
- Where
- Chengdu, Shanghai
- Életkor
- 18 év to 75 év
- People
- 78
- Run by
- Ruijin Hospital
See details and how to joinNCT07885319 - 2. fázisNot yet taking people in KínaFirst-line Treatment With Dual Immunotherapy Combined With Anti-angiogenesis for Unresectable Advanced Malignant Peritoneal Mesothelioma
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 19
- Run by
- Fudan University
See details and how to joinNCT07893340 - 1/2. fázisTaking peopleStudy of ISM6331 in Participants With Advanced/Metastatic Mesothelioma or Other Advanced Solid Tumors
- Where
- Beijing, Guangzhou, Shanghai, Zhengzhou
- Életkor
- 18 év and over
- People
- 160 worldwide
- Run by
- InSilico Medicine Hong Kong Limited
See details and how to joinNCT06566079 - 2. fázisTaking peopleStudy of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors
- Where
- Anyang, Beijing, Bengbu, Changchun, Changsha, Chengdu, Chongqing, Dongguan, Fuzhou, Guangzhou, Hangzhou, Harbin, Hefei, Jining, Kunming, Nanchang, Nanjing, Nanning, Shandong, Shanghai, Shenyang, Tianjin, Wuhan, Wuhou District, Zhengzhou
- Életkor
- 18 év to 64 év
- People
- 257 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06535607 · EU 2025-523947-36-00 - 1. fázisTaking peopleAPG-2449 in Patients With Advanced Solid Tumors
- Where
- Beijing, Changsha, Fuzhou, Guangzhou, Hangzhou, Wuhan, Zhengzhou
- Életkor
- 18 év and over
- People
- 165
- Run by
- Ascentage Pharma Group Inc.
See details and how to joinNCT03917043 - No phaseTaking peoplePTC-Guided Therapy for Peritoneal Mesothelioma
- Where
- Beijing
- Életkor
- 18 év to 85 év
- People
- 347
- Run by
- Beijing Tsinghua Chang Gung Hospital
See details and how to joinNCT07330271 - 2. fázisNot yet taking people in KínaIparomlimab Plus Tovorilimab Combined With Bevacizumab and Chemotherapy as First-Line Treatment for Advanced Mesothelioma
- Where
- Shanghai
- Életkor
- 18 év to 75 év
- People
- 37
- Run by
- Fudan University
See details and how to joinNCT07514793 - 1/2. fázisTaking peopleDual-Target MSLN/FAP CAR-NK Cells for Pleural and Peritoneal Mesothelioma
- Where
- Shenzhen
- Életkor
- 18 év to 75 év
- People
- 36
- Run by
- Beijing Biotech
See details and how to joinNCT07510815 - 1/2. fázisNot yet taking people in KínaStudy of TYK-01054 Capsules in Patients With Advanced Solid Tumors
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 219
- Run by
- TYK Medicines, Inc
See details and how to joinNCT07282873 - 2. fázisTaking peopleFirst Line Sintilimab Combined With Anlotinib and Platinum Doublet Chemotherapy in Malignant Pleural Mesothelioma
- Where
- Beijing, Taiyuan
- Életkor
- 18 év and over
- People
- 29
- Run by
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT05188859 - 2. fázisTaking peopleMulticenter Single-Arm Study of Ivonescimab (AK112) Combined with Chemotherapy in Pretreated Pleural Mesothelioma
- Where
- Changchun
- Életkor
- 18 hónap to 75 hónap
- People
- 25
- Run by
- The First Hospital of Jilin University
See details and how to joinNCT06875076 - 1. fázisTaking peopleA Study of MT027 in Patients with Pleural Malignant Tumors
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 18
- Run by
- Suzhou Maximum Bio-tech Co., Ltd.
See details and how to joinNCT06726564 - 2. fázisTaking peopleSintilimab, Bevacizumab, Pemetrexed, and Cisplatin for Unresectable MPeM
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 28
- Run by
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT06543069 - 1. fázisTaking peopleGPC3/Mesothelin-CAR-γδT Cells Against Cancers
- Where
- Guangzhou
- Életkor
- 18 év to 75 év
- People
- 30
- Run by
- Second Affiliated Hospital of Guangzhou Medical University
See details and how to joinNCT06196294